| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vaxcyte, Inc. | Director | Common Stock | 5.63K | $364K | $64.78 | Jun 13, 2023 | Direct |
| Passage BIO, Inc. | Director | Director Stock Option (Right to Buy) | 21.6K | May 25, 2023 | Direct | ||
| Vaxcyte, Inc. | Director | Stock Option (right to buy) | 15K | Jun 13, 2023 | Direct | ||
| Trillium Therapeutics Inc. | Director | Stock Option (Right to Buy) | 0 | Nov 17, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | Jun 13, 2023 | 2 | $0 | 4 | Jun 15, 2023 | Director |
| PASG | Passage BIO, Inc. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
| PASG | Passage BIO, Inc. | Jul 5, 2022 | 1 | $0 | 4 | Jul 6, 2022 | Director |
| PASG | Passage BIO, Inc. | Jul 2, 2022 | 0 | $0 | 3 | Jul 6, 2022 | Director |
| PCVX | Vaxcyte, Inc. | Jun 1, 2022 | 2 | $0 | 4 | Jun 3, 2022 | Director |
| TRIL | Trillium Therapeutics Inc. | Nov 17, 2021 | 1 | $0 | 4 | Nov 19, 2021 | Director |
| PCVX | Vaxcyte, Inc. | Oct 27, 2021 | 1 | $0 | 4 | Oct 29, 2021 | Director |
| PCVX | Vaxcyte, Inc. | Oct 27, 2021 | 0 | $0 | 3 | Oct 29, 2021 | Director |